Search Results - Cheolwon Suh

Refine Results
  1. 1
    Serum beta-2 microglobulin in malignant lymphomas: an old but powerful prognostic factor

    Serum beta-2 microglobulin in malignant lymphomas: an old but powerful prognostic factor by Changhoon Yoo, Dok Hyun Yoon, Cheolwon Suh

    Published 2014
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    CSF-1R Expression in Tumor-Associated Macrophages Is Associated With Worse Prognosis in Classical Hodgkin Lymphoma

    CSF-1R Expression in Tumor-Associated Macrophages Is Associated With Worse Prognosis in Classical Hodgkin Lymphoma by Young Wha Koh, Chan-Sik Park, Dok Hyun Yoon, Cheolwon Suh, Jooryung Huh

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    CD163 Expression Was Associated with Angiogenesis and Shortened Survival in Patients with Uniformly Treated Classical Hodgkin Lymphoma

    CD163 Expression Was Associated with Angiogenesis and Shortened Survival in Patients with Uniformly Treated Classical Hodgkin Lymphoma by Young Wha Koh, Chan Sik Park, Dok Hyun Yoon, Cheolwon Suh, Jooryung Huh

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Distribution of lymphoid neoplasms in the Republic of Korea: Analysis of 5318 cases according to the World Health Organization classification

    Distribution of lymphoid neoplasms in the Republic of Korea: Analysis of 5318 cases according to the World Health Organization classification by Sun Och Yoon, Cheolwon Suh, Dae Ho Lee, Hyun‐Sook Chi, Chan Jeoung Park, Seongsoo Jang, Hai‐Rim Shin, Bong‐Hee Park, Jooryung Huh

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Prognostic Significance of the Ratio of Absolute Neutrophil Count to Absolute Lymphocyte Count in Classic Hodgkin Lymphoma

    Prognostic Significance of the Ratio of Absolute Neutrophil Count to Absolute Lymphocyte Count in Classic Hodgkin Lymphoma by Young Wha Koh, Hyo Jeong Kang, Chan-Sik Park, Dok Hyun Yoon, Shin Kim, Cheolwon Suh, Ji Eun Kim, Jong Kyu Woo, Jooryung Huh

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Phase I study of proteasome inhibitor bortezomib plus CHOP in patients with advanced, aggressive T-cell or NK/T-cell lymphoma

    Phase I study of proteasome inhibitor bortezomib plus CHOP in patients with advanced, aggressive T-cell or NK/T-cell lymphoma by J. Lee, Cheolwon Suh, Hye Jin Kang, Baek‐Yeol Ryoo, Jooryung Huh, Young Hyeh Ko, Hyeon‐Seok Eom, Kihyun Kım, K. Park, W. S. Kim

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Prognostic Value of Tumor <sup>18</sup>F-FDG Uptake in Patients with Untreated Extranodal Natural Killer/T-Cell Lymphomas of the Head and Neck

    Prognostic Value of Tumor <sup>18</sup>F-FDG Uptake in Patients with Untreated Extranodal Natural Killer/T-Cell Lymphomas of the Head and Neck by Cheolwon Suh, Yoon‐Koo Kang, Jong‐Lyel Roh, Mi Ra Kim, Jae Seung Kim, Jooryung Huh, Jeong Hyun Lee, Yong Ju Jang, Bong-Jae Lee

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    The Ratio of the Absolute Lymphocyte Count to the Absolute Monocyte Count Is Associated with Prognosis in Hodgkin's Lymphoma: Correlation with Tumor-Associated Macrophages

    The Ratio of the Absolute Lymphocyte Count to the Absolute Monocyte Count Is Associated with Prognosis in Hodgkin's Lymphoma: Correlation with Tumor-Associated Macrophages by Young Wha Koh, Hyo Jeong Kang, Chan-Sik Park, Dok Hyun Yoon, Shin Kim, Cheolwon Suh, Heounjeong Go, Ji Eun Kim, Chul‐Woo Kim, Jooryung Huh

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Complete Remission Status before Autologous Stem Cell Transplantation Is an Important Prognostic Factor in Patients with Multiple Myeloma Undergoing Upfront Single Autologous Transplantation

    Complete Remission Status before Autologous Stem Cell Transplantation Is an Important Prognostic Factor in Patients with Multiple Myeloma Undergoing Upfront Single Autologous Trans... by Jin Seok Kim, Kihyun Kım, June‐Won Cheong, Yoo Hong Min, Cheolwon Suh, Hawk Kim, Deog Yeon Jo, Hun Mo Ryoo, Sung Soo Yoon, Jae Hoon Lee

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Randomized Phase III Trial of Gefitinib versus Docetaxel in Non–Small Cell Lung Cancer Patients Who Have Previously Received Platinum-Based Chemotherapy

    Randomized Phase III Trial of Gefitinib versus Docetaxel in Non–Small Cell Lung Cancer Patients Who Have Previously Received Platinum-Based Chemotherapy by Dae Ho Lee, Keunchil Park, Joo Hang Kim, Jong Seok Lee, Sang Won Shin, Jin Hyoung Kang, Myung‐Ju Ahn, Jin Seok Ahn, Cheolwon Suh, Sang-We Kim

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    [18F]Fluorothymidine Positron Emission Tomography before and 7 Days after Gefitinib Treatment Predicts Response in Patients with Advanced Adenocarcinoma of the Lung

    [18F]Fluorothymidine Positron Emission Tomography before and 7 Days after Gefitinib Treatment Predicts Response in Patients with Advanced Adenocarcinoma of the Lung by Hee-Jung Sohn, You-Jung Yang, Jin‐Sook Ryu, Seung Jun Oh, Ki Chun Im, Dae Hyuk Moon, Dae Ho Lee, Cheolwon Suh, Jung‐Shin Lee, Sang‐We Kim

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    When do we need central nervous system prophylaxis in patients with extranodal NK/T-cell lymphoma, nasal type?

    When do we need central nervous system prophylaxis in patients with extranodal NK/T-cell lymphoma, nasal type? by S.J. Kim, Sung Yong Oh, Jin Young Hong, Myung Hee Chang, D.H. Lee, Jooryung Huh, Young Hyeh Ko, Yong Chan Ahn, Hee Ju Kim, Cheolwon Suh, Kihyun Kım, Woo Seob Kim

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Beyond first-line non-anthracycline-based chemotherapy for extranodal NK/T-cell lymphoma: clinical outcome and current perspectives on salvage therapy for patients after first relapse and progression of disease

    Beyond first-line non-anthracycline-based chemotherapy for extranodal NK/T-cell lymphoma: clinical outcome and current perspectives on salvage therapy for patients after first rela... by Sung Hee Lim, Jung Yong Hong, Soon Thye Lim, Huangming Hong, J. Templeton Arnoud, Weili Zhao, Do Hyun Yoon, Tiffany Tang, Jaeil Cho, S. Park, Young Hyeh Ko, S. J. Kim, Cheolwon Suh, Tongyu Lin, Woo Seob Kim

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer

    A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric ca... by Noe Kyeong Kim, Young Suk Park, Dae Seog Heo, Cheolwon Suh, Sang Yong Kim, Keun Chil Park, Yoon‐Koo Kang, Dong Bok Shin, Heung Tae Kim, Hyo Jin Kim, Won Ki Kang, Chang In Suh, Yung‐Jue Bang

    Published 1993
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Multicenter Phase II Study of Bendamustine Plus Rituximab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

    Multicenter Phase II Study of Bendamustine Plus Rituximab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma by Ken Ohmachi, Nozomi Niitsu, Toshiki Uchida, Seok Jin Kim, Kiyoshi Ando, Naoki Takahashi, Naoto Takahashi, Naokuni Uike, Hyeon Seok Eom, Yee Soo Chae, Takashi Terauchi, Ukihide Tateishi, Mitsuaki Tatsumi, Won Seog Kim, Kensei Tobinai, Cheolwon Suh, Michinori Ogura

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Matched‐pair analysis comparing the outcomes of primary breast and nodal diffuse large B‐cell lymphoma in patients treated with rituximab plus chemotherapy

    Matched‐pair analysis comparing the outcomes of primary breast and nodal diffuse large B‐cell lymphoma in patients treated with rituximab plus chemotherapy by Ho‐Young Yhim, Jin Seok Kim, Hye Jin Kang, Seok Jin Kim, Won Seog Kim, Chul Won Choi, Hyeon Seok Eom, Jeong‐A. Kim, Jae Hoon Lee, Jong-Ho Won, Hyeok Shim, Jooryung Huh, Daeho Lee, Cheolwon Suh, Jae‐Yong Kwak

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Clinical Outcomes and Prognostic Factors of Up-Front Autologous Stem Cell Transplantation in Patients with Extranodal Natural Killer/T Cell Lymphoma

    Clinical Outcomes and Prognostic Factors of Up-Front Autologous Stem Cell Transplantation in Patients with Extranodal Natural Killer/T Cell Lymphoma by Ho‐Young Yhim, Jin Seok Kim, Yeung‐Chul Mun, Joon Ho Moon, Yee Soo Chae, Yong Park, Jae‐Cheol Jo, Seok Jin Kim, Dok Hyun Yoon, June‐Won Cheong, Jae-Yong Kwak, Je‐Jung Lee, Won Seog Kim, Cheolwon Suh, Deok‐Hwan Yang

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    A phase II study of everolimus (RAD001), an mTOR inhibitor plus CHOP for newly diagnosed peripheral T-cell lymphomas

    A phase II study of everolimus (RAD001), an mTOR inhibitor plus CHOP for newly diagnosed peripheral T-cell lymphomas by Seung Ju Kim, Dong-Yeop Shin, Jin Sung Kim, Dok Hyun Yoon, W.S. Lee, H. Lee, Young-Rok Do, Hye Jin Kang, Hyeon‐Seok Eom, Young Hyeh Ko, S.H. Lee, Hae Young Yoo, Min Eui Hong, Cheolwon Suh, Woo Seob Kim

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Efficacy of Brentuximab Vedotin in Relapsed or Refractory High-CD30–Expressing Non-Hodgkin Lymphomas: Results of a Multicenter, Open-Labeled Phase II Trial

    Efficacy of Brentuximab Vedotin in Relapsed or Refractory High-CD30–Expressing Non-Hodgkin Lymphomas: Results of a Multicenter, Open-Labeled Phase II Trial by Seok Jin Kim, Dok Hyun Yoon, Jin Seok Kim, Hye Jin Kang, Hye Won Lee, Hyeon‐Seok Eom, Jung Yong Hong, Junhun Cho, Young Hyeh Ko, Jooryung Huh, Woo‐Ick Yang, Weon Seo Park, Seung‐Sook Lee, Cheolwon Suh, Won Seog Kim

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Extranodal natural killer/T-cell lymphoma from skin or soft tissue: suggestion of treatment from multinational retrospective analysis

    Extranodal natural killer/T-cell lymphoma from skin or soft tissue: suggestion of treatment from multinational retrospective analysis by Hee Kyung Ahn, Cheolwon Suh, Shih‐Sung Chuang, Junji Suzumiya, Young Hyeh Ko, S. J. Kim, Jooryung Huh, Dok Hyun Yoon, Sung Yong Oh, J.S. Kim, S. I. Lee, K.W. Park, P‐P Hsieh, Shota Nakamura, T. Yoshino, Kei Ito, T Nagatani, Kazuo Oshimi, Ritsuro Suzuki, W. S. Kim

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: